DYNE THERAPEUTICS INC. - COMMON STOCK
29,90
25-ноября-24 13:28:38
15 мин. задержка
Акции
+0,20
+0,69%
Сегодняшний диапазон
29,19 - 30,77
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
13 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
05 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at February Investor Conferences
01 фев 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
11 янв 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
05 янв 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
04 янв 2024 22:46:36 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
03 янв 2024 16:25:00 Источник Nasdaq GlobeNewswire
-
02 янв 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at November Investor Conferences
07 ноя 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
30 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at October Investor Conferences
28 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
20 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
05 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
03 авг 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Healthcare Conference
01 июн 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101
25 май 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
17 май 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
11 май 2023 07:30:00 Источник Nasdaq GlobeNewswire